Micron (MU) stock climbs 42% YTD ahead of Q2 earnings. Analysts project 460% EPS growth to $8.74 and revenue of $19B. Wells Fargo lifts target to $470. The postMicron (MU) stock climbs 42% YTD ahead of Q2 earnings. Analysts project 460% EPS growth to $8.74 and revenue of $19B. Wells Fargo lifts target to $470. The post

Micron (MU) Stock Surges Ahead of Wednesday Earnings as Analysts Raise Targets

2026/03/13 17:14
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Quick Summary

  • Micron (MU) shares have rallied 42% this year and an impressive 324% over the last twelve months, powered by AI-driven memory chip demand.
  • The company’s Q2 FY26 financial results arrive March 18, with analyst consensus targeting EPS of $8.74 — representing a 460% yearly increase — alongside $19.03 billion in revenue.
  • Aaron Rakers from Wells Fargo boosted his price objective to $470, expressing strong conviction in HBM4 technology and sustainable earnings prospects.
  • Mizuho analysts continue their Outperform stance with a $480 target, projecting May quarter sales of $25 billion, approximately 8% beyond consensus estimates.
  • TipRanks Crowd Wisdom analysis indicates “Very Positive” investor sentiment across more than 853,000 monitored portfolios.

Micron (MU) prepares to take center stage this week. The semiconductor memory manufacturer releases its Q2 FY26 financial results on March 18, and momentum appears favorable leading into the announcement.


MU Stock Card
Micron Technology, Inc., MU

Shares have advanced 42% since the start of the year and an extraordinary 324% over twelve months. This remarkable performance stems from constrained memory supplies, ascending chip valuations, and persistent demand from data center providers expanding AI capabilities.

Analysts tracking Micron anticipate Q2 FY26 earnings per share of $8.74, marking a 460% increase compared to the previous year. Revenue projections stand at $19.03 billion, reflecting 136% annual growth.

These figures are substantial — and market watchers believe they could move even higher.

Mizuho maintained its Outperform designation along with a $480 price objective, forecasting May quarter revenue reaching $25.0 billion with EPS of $11.13. This represents approximately 8% above current Wall Street expectations. For the August period, analysts project $27.2 billion in sales, similarly outpacing consensus by roughly 7%.

Aaron Rakers, a five-star-rated analyst at Wells Fargo, reinforced his optimistic stance. He maintained his Buy recommendation while increasing his price target from $410 to $470, highlighting sustained earnings visibility and robust momentum in high-bandwidth memory (HBM4) technology.

Rakers currently projects peak earnings potential of $50 to $60 per share, with normalized through-cycle earnings capacity between $30 and $40 per share. He noted that Micron has completely allocated or committed all 2026 HBM production — and accelerated volume deliveries by one full quarter.

HBM4 Technology Takes Priority

HBM4 developments should dominate discussion during the March 18 earnings presentation. Rakers anticipates Micron will discuss competitive dynamics surrounding Nvidia’s forthcoming Rubin chip architecture, including 11 Gbps pin speed capabilities and advantages from its proprietary CMOS base die technology.

He also highlighted a prospective 20% to 30% elevation in HBM4 pricing compared to HBM3e during the latter half of 2026 as product mix transitions.

Mizuho reinforced the positive HBM outlook, observing that HBM3e demand continues robustly before HBM4 product launches, with HBM4 commanding 30% to 45% premium pricing versus earlier generations.

The firm additionally identified positive trends in NAND memory, propelled by AI requirements for QLC eSSD solutions and migration toward advanced flash technology. Hyperscaler capital expenditures are projected to surge 59% year-over-year throughout 2026, creating favorable conditions for Micron’s pricing strategies.

Wall Street Outlook

Beyond Wells Fargo and Mizuho, additional analysts have elevated their targets. Wolfe Research raised its objective to $500, incorporating revised DRAM and NAND pricing models. Aletheia Capital established a $650 target, doubling its FY2026 profit forecast based on AI-related demand.

Among 27 Wall Street analysts covering Micron, the consensus rating stands at Strong Buy, comprising 26 Buy recommendations and one Hold. The average price target of $440.67 suggests approximately 9% potential appreciation from present levels.

On the product front, Micron recently delivered 256GB SOCAMM2 modules — representing the industry’s largest-capacity LPDRAM module designed for AI servers. These modules incorporate the first monolithic 32Gb LPDDR5X die and provide a one-third capacity enhancement over earlier versions.

Micron shares currently trade around $405.

The post Micron (MU) Stock Surges Ahead of Wednesday Earnings as Analysts Raise Targets appeared first on Blockonomi.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Unprecedented US Military Operation Shakes Middle East Security

Unprecedented US Military Operation Shakes Middle East Security

The post Unprecedented US Military Operation Shakes Middle East Security appeared on BitcoinEthereumNews.com. Trump Kharg Island Airstrike: Unprecedented US Military
Share
BitcoinEthereumNews2026/03/14 07:25
Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

The post Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme appeared on BitcoinEthereumNews.com. Michael Saylor has responded sharply
Share
BitcoinEthereumNews2026/03/14 07:22
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11